🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 1b, multicenter, 2-part study of ALRN-6924 for the preventi...
Status
Terminated
Location
Arizona Cancer Center
Start Date
2019-09-03
Trial ID
NCT04022876
Treatments Being Tested
This is a multicenter screening protocol designed to identify patients with...
Status
Terminated
Location
Southern Cancer Center
Start Date
2021-01-19
Trial ID
NCT04698681
A Randomized, Double-blind, Multi-center, Phase III Clinical Study of AK112...
Status
Active Not Recruiting
Location
CBCC Global Research
Start Date
2023-05-04
Trial ID
NCT06396065
Treatments Being Tested
The purpose of this study is to assess the safety and efficacy of pemetrexe...
Status
Completed
Location
El Camino Hospital Cancer Center ( Site 0529)
Start Date
2019-03-25
Trial ID
NCT03829319
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of pemetre...
Status
Completed
Location
Cedars-Sinai Medical Center ( Site 0070)
Start Date
2018-06-29
Trial ID
NCT03515837
Treatments Being Tested
The purpose of this study is to assess if adding LY3537982 (olomorasib) in ...
Status
Recruiting
Location
Clearview Cancer Institute
Start Date
2023-12-21
Trial ID
NCT06119581
Treatments Being Tested
This study is researching an investigational drug called fianlimab (also ca...
Status
Active Not Recruiting
Location
Arizona Clinical Research Center
Start Date
2023-08-08
Trial ID
NCT05800015
Treatments Being Tested
The aim of this study is to combine AZD1775 with standard front-line chemot...
Status
Terminated
Location
Research Site
Start Date
2014-03
Trial ID
NCT02087241
Treatments Being Tested
The purpose of this study is to assess the efficacy and safety of pembroliz...
Status
Active Not Recruiting
Location
University of South Alabama, Mitchell Cancer Institute ( Site 0003)
Start Date
2020-07-06
Trial ID
NCT04380636
This study aimed to evaluate the safety and effectiveness of ociperlimab co...
Status
Completed
Location
Valkyrie Clinical Trials
Start Date
2021-11-16
Trial ID
NCT05014815
Treatments Being Tested